Alembic Pharmaceuticals reports over 58% fall in Q2 consolidated net profit.
The company has reported 54.88% fall in its net profit at Rs 113.83 crore for the quarter under review as compared to Rs 252.27 crore for the same quarter in the previous year. Total income of the company decreased by 10.17% at Rs 837.13 crore for the quarter under review as compared Rs 931.90 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 58.47% fall in its net profit after taxes, minority interest and share of profit /(Loss) of associates at Rs 119.83 crore for the quarter ended September 30, 2016 as compared to Rs 288.51 crore for the same quarter in the previous year. Total Income of the company has decreased by 13.57% to Rs 879.92 crore for quarter under review from Rs 1018.12 crore for the quarter ended September 30, 2015.
